Skip to content

Insider · CIK 0001847811

Brian Lee Brown

cfoofficer

Files at CODX (Co-Diagnostics, Inc.). First filing -, latest -.

In brief

Brian Lee Brown files SEC Form 4 as CFO at CODX (Co-Diagnostics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Brian Lee Brown has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 23 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 23, 2026CODX
Co-Diagnostics, Inc.
AGrant or award
Common Stock
+3,750$0.00$023,729May 27, 2026
May 23, 2026CODX
Co-Diagnostics, Inc.
DDisposition to issuer
Common Stock
-1,350$5.07$6,84522,379May 27, 2026
May 23, 2026CODX
Co-Diagnostics, Inc.
MOption exercise
Restricted Stock Unitderivative
-3,750$0.00$07,500May 27, 2026
Nov 23, 2025CODX
Co-Diagnostics, Inc.
AGrant or award
Common Stock
+134,167$0.00$0640,078Nov 24, 2025
Nov 23, 2025CODX
Co-Diagnostics, Inc.
DDisposition to issuer
Common Stock
-40,723$0.35$14k599,355Nov 24, 2025
Nov 23, 2025CODX
Co-Diagnostics, Inc.
MOption exercise
Restricted Stock Unitderivative
-134,167$0.00$0337,500Nov 24, 2025
Aug 13, 2025CODX
Co-Diagnostics, Inc.
AGrant or award
Restricted Stock Unitsderivative
+225,000$0.00$0471,667Aug 15, 2025
May 23, 2025CODX
Co-Diagnostics, Inc.
AGrant or award
Common Stock
+134,166$0.00$0554,072May 27, 2025
May 23, 2025CODX
Co-Diagnostics, Inc.
DDisposition to issuer
Common Stock
-48,161$0.24$12k505,911May 27, 2025
May 23, 2025CODX
Co-Diagnostics, Inc.
MOption exercise
Restricted Stock Unitderivative
-134,166$0.00$0246,667May 27, 2025
Nov 23, 2024CODX
Co-Diagnostics, Inc.
AGrant or award
Common Stock
+134,167$0.00$0460,721Nov 25, 2024
Nov 23, 2024CODX
Co-Diagnostics, Inc.
DDisposition to issuer
Common Stock
-40,816$1.01$41k419,905Nov 25, 2024
Nov 23, 2024CODX
Co-Diagnostics, Inc.
MOption exercise
Restricted Stock Unitderivative
-134,167$0.00$0380,833Nov 25, 2024
May 23, 2024CODX
Co-Diagnostics, Inc.
AGrant or award
Common Stock
+113,334$0.00$0326,554May 28, 2024
May 23, 2024CODX
Co-Diagnostics, Inc.
DDisposition to issuer
Common Stock
-35,865$1.09$39k290,689May 28, 2024
May 23, 2024CODX
Co-Diagnostics, Inc.
MOption exercise
Restricted Stock Unitderivative
-113,334$0.00$0515,000May 28, 2024
Apr 26, 2024CODX
Co-Diagnostics, Inc.
AGrant or award
Restricted Stock Unitsderivative
+225,000$0.00$0628,334Apr 29, 2024
Nov 23, 2023CODX
Co-Diagnostics, Inc.
AGrant or award
Common Stock
+118,332$0.00$0249,345Nov 27, 2023
Nov 23, 2023CODX
Co-Diagnostics, Inc.
DDisposition to issuer
Common Stock
-36,125$1.26$46k213,220Nov 27, 2023
Nov 23, 2023CODX
Co-Diagnostics, Inc.
MOption exercise
Restricted Stock Unitderivative
-118,332$0.00$0403,334Nov 27, 2023
Nov 23, 2022CODX
Co-Diagnostics, Inc.
AGrant or award
Common Stock
+59,167$0.00$091,423Nov 23, 2022
Nov 23, 2022CODX
Co-Diagnostics, Inc.
DDisposition to issuer
Common Stock
-18,187$3.47$63k73,236Nov 23, 2022
Nov 23, 2022CODX
Co-Diagnostics, Inc.
MOption exercise
Restricted Stock Unitsderivative
-59,167$0.00$0247,500Nov 23, 2022

Questions about Brian Lee Brown

Answered from the filings on this page, as of the latest one.

Is Brian Lee Brown buying or selling?

Brian Lee Brown has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Brian Lee Brown's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Brian Lee Brown has 0.

Where does Brian Lee Brown file Form 4?

Brian Lee Brown has filed Form 4 at CODX (Co-Diagnostics, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Brian Lee Brown: insider trades and track record | InsiderTell